Literature DB >> 31302040

Risk for Heart Failure: The Opportunity for Prevention With the American Heart Association's Life's Simple 7.

Alicia Uijl1, Stefan Koudstaal2, Ilonca Vaartjes3, Jolanda M A Boer4, W M Monique Verschuren4, Yvonne T van der Schouw3, Folkert W Asselbergs5, Arno W Hoes3, Ivonne Sluijs3.   

Abstract

OBJECTIVES: The aim of this study is to determine whether combinations of specific Life's Simple 7 (LS7) components are associated with reduced risk for heart failure (HF).
BACKGROUND: The American Heart Association recommends the concept of LS7: healthy behaviors that have been shown to reduce cardiovascular disease.
METHODS: A total of 37,803 participants from the EPIC-NL (European Prospective Investigation Into Cancer and Nutrition-Netherlands) cohort were included (mean age: 49.4 ± 11.9 years, 74.7% women). The LS7 score ranged from 0 to 14 and was calculated by assigning 0, 1, or 2 points for smoking, physical activity, body mass index, diet, blood pressure, total cholesterol, and blood glucose. An overall ideal score (11 to 14 points) was present in 23.2% of participants, an intermediate score (9 or 10 points) in 35.3%, and an inadequate score (0 to 8 points) in 41.5%.
RESULTS: Over a median follow-up period of 15.2 years (interquartile range: 14.1 to 16.5 years), 690 participants (1.8%) developed HF. In Cox proportional hazards models, ideal and intermediate LS7 scores were associated with reduced risk for HF compared with the inadequate category (hazard ratio: 0.45 [95% confidence interval (CI): 0.34 to 0.60] and hazard ratio: 0.53 [95% CI: 0.44 to 0.64], respectively). Our analyses show that combinations with specific LS7 components, notably glucose, body mass index, smoking, and blood pressure, are associated with a lower incidence of HF.
CONCLUSIONS: A healthy lifestyle, as reflected in an ideal LS7 score, was associated with a 55% lower risk for HF compared with an inadequate LS7 score. Preventive strategies that target combinations of specific LS7 components could have a significant impact on decreasing incident HF in the population at large.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Life’s Simple 7; cardiovascular disease risk factors; healthy lifestyle; heart failure

Year:  2019        PMID: 31302040     DOI: 10.1016/j.jchf.2019.03.009

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  11 in total

Review 1.  Cardiovascular Risk Reduction by Pharmacists at the Workplace.

Authors:  Tracy E Macaulay; Sarah Schaidle; Nathan Wayne
Journal:  Curr Cardiol Rep       Date:  2020-02-07       Impact factor: 2.931

Review 2.  Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?

Authors:  Kevin S Shah; James C Fang
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

Review 3.  New strategies and therapies for the prevention of heart failure in high-risk patients.

Authors:  Michael M Hammond; Ian K Everitt; Sadiya S Khan
Journal:  Clin Cardiol       Date:  2022-06       Impact factor: 3.287

4.  Enter Stage A, Exit Stage D: A Curtain Call for Delay in Heart Failure Prevention.

Authors:  Nosheen Reza; Mariell Jessup
Journal:  Circ Heart Fail       Date:  2019-09-11       Impact factor: 8.790

Review 5.  Risk-Based Approach for the Prediction and Prevention of Heart Failure.

Authors:  Arjun Sinha; Deepak K Gupta; Clyde W Yancy; Sanjiv J Shah; Laura J Rasmussen-Torvik; Elizabeth M McNally; Philip Greenland; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Circ Heart Fail       Date:  2021-02-04       Impact factor: 8.790

6.  Refocusing on the Primary Prevention of Heart Failure.

Authors:  Lua A Jafari; Rachel M Suen; Sadiya S Khan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-05-29

7.  Heart Failure Risk Associated With Severity of Modifiable Heart Failure Risk Factors: The ARIC Study.

Authors:  Carine E Hamo; Lucia Kwak; Dan Wang; Roberta Florido; Justin B Echouffo-Tcheugui; Roger S Blumenthal; Laura Loehr; Kunihiro Matsushita; Vijay Nambi; Christie M Ballantyne; Elizabeth Selvin; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Chiadi E Ndumele
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

Review 8.  Physical activity and the risk of heart failure: a systematic review and dose-response meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Sabrina Schlesinger; Michael F Leitzmann; Serena Tonstad; Teresa Norat; Elio Riboli; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2020-12-17       Impact factor: 8.082

9.  Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics.

Authors:  Nilay S Shah; Rebecca Molsberry; Jamal S Rana; Stephen Sidney; Simon Capewell; Martin O'Flaherty; Mercedes Carnethon; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  BMJ       Date:  2020-08-13

Review 10.  Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.

Authors:  Merle M Krebber; Christian G M van Dijk; Robin W M Vernooij; Maarten M Brandt; Craig A Emter; Christoph D Rau; Joost O Fledderus; Dirk J Duncker; Marianne C Verhaar; Caroline Cheng; Jaap A Joles
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.